That is necessary, due to the fact that the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. To put it simply, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (jeff brown stock picks 2021). Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're designed to do. This was a development almost no one saw. However it's going to have profound ramifications for curing disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of financial investment chances in this area, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown genetic sequencing stock). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps substantially prior to going greater - tech stocks. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. However that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a trusted 170-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. second wave. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are many excellent private business on the brink of striking the public markets And I have actually been dealing with a brand-new way for you to invest even before these business go public.
This chance has actually been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Journal. Routine Journal readers know that tech isn't our usual beat (jeff brown 2021 stock predictions). And when it comes to tech investing, we leave it to the professionals. The good news is, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (jeff brown 1 biotech). In fact, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These trends are experiencing rapid growth and developing extraordinary opportunities for financiers. I want to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. melania trump. However despite what numerous readers may think, this is a trend that's simply beginning. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this ultimately resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown biotech stocks). Losing 2 months of production and sales truly impacts the number of 5G gadgets are offered in the fiscal year. When you think about all of that, selling 250 million systems is amazing. More significantly, the delays triggered by the pandemic created a lots of suppressed need. Which demand is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G devices will be shipped in 2021 - jeff brown biotech stocks. And that's not my only 5G prediction When I have actually discussed 5G in the past, I have actually described its three different phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Phase Three, 5G services start to be offered (exponential growth). That's when we start to see applications operating on 5G networks. Think of things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage Three by this summer season. This begins something of a virtuous cycle: Many individuals don't truly care about the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open a suite of extraordinary applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these technologies require 5G. The investment chances moving forward will be enormous. Stepping far from 5G, the next essential technology I visualize in 2021 is CRISPR genetic modifying. CRISPR means "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not function correctly. CRISPR utilizes a comparable idea however with our genetic code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And throughout that time, there were truly just 3 companies running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're treating illness and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This whole industry is effectively a greenfield chance.
There's room for numerous companies to exist in this area. self-driving cars. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software application can properly forecast the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is very important because the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however numerous drug therapies produced utilizing this technology. This was among those breakthroughs that nearly nobody saw. But it's going to have profound implications for curing disease. And, obviously, there will be lots of financial investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps substantially before going higher. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin - longtime readers. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my recommendation. But at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. tech stock. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, however we could not separately confirm this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to select winning innovation stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an outstanding viewpoint on the marketplace. He's constantly on the hunt for brand-new chances, and he shares many of his best choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he successfully anticipated some of the greatest economic events of the previous 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal every time, however Jeff Brown's precise predictions have earned him legions of devoted fans. That says a lot about his ability. The Near Future Report is published by Brownstone Research study, a prominent monetary research publisher. Brownstone Research study uses a number of research study services with a broad range of specializations - jeff brown prediction for 2021.
The company is also associated with Bonner & Partners, another well-respected research study publisher - korean actress. On its site, Brownstone states its objective is to supply retail investors with professional-grade research: "For too long, the very best investment research has not been offered to individual financiers. It has actually been normally reserved for financial investment banks, hedge funds, personal equity, and high-net-worth customers. melania trump. The objective of Brownstone Research study is to make that type of exclusive research study readily available to any investors looking to acquire an edge in the markets. The objective is easy to provide special and lucrative financial investment research study found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also functions as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you know even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. exponential tech investor. Everything he touches relies on gold! Jeff is well aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown thinks S.A.V. biotech stocks. could be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 cutting-edge technologies: artificial intelligence and electric vehicles. Musk hopes the mix will assist him develop the first fully-autonomous, self-driving automobiles ever. It's nothing except the vehicle industry's Holy Grail. As you know, electrical lorries and self-driving car stocks have actually been big this year, however the Wall Street machine has approved buzz without much tangible result. Regardless of an extreme increase in competitors over the previous few years, Brown still thinks Musk has the best opportunity of putting it all together.
tech could be the magic string that connects it all together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transport. Generally, this innovation would enable you to rent your car as an autonomous, self-driving taxi when you're not using it. You simply get out of the cars and truck and press a button on an app that informs the car to "join the fleet." Next thing you know, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a large chunk of the revenues. It sounds insane, but it could be closed than you think.